Follistatin is a novel therapeutic target and biomarker in <scp>FLT</scp> 3/ <scp>ITD</scp> acute myeloid leukemia
2020 · EMBO Molecular Medicine · 16 citations
https://doi.org/10.15252/emmm.201910895
C
Cheuk Him Man
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
797
Citations
13
h-index
14
i10-index
Cheuk Him Man is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Cancer, Hypoxia, and Metabolism. The author has an h-index of 13, co-authored 30 publications.
ORCID: 0000-0001-9478-2194Papers by this author
worksFollistatin is a novel therapeutic target and biomarker in <scp>FLT</scp> 3/ <scp>ITD</scp> acute myeloid leukemia
2020 · EMBO Molecular Medicine · 6 citations
https://doi.org/10.15252/emmm.202012911
Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implication
2022 · Leukemia · 4 citations
https://doi.org/10.1038/s41375-022-01606-0
Metabolic regulation in normal and leukemic stem cells
2024 · Trends in Pharmacological Sciences · 2 citations
https://doi.org/10.1016/j.tips.2024.08.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat